Clinical Research Directory

Inclusion Criteria: * Patients diagnosed with peripheral T-cell lymphoma (PTCL) by histopathology from June 2026 to December 2029 and detected by gene sequencing (NGS) with different molecular subtypes. * Patients diagnosed with PTCL by histopathology from January 2026 to June 2026 and NGS detection can be performed if there is tumor tissue. * Fully understand the study, voluntarily sign the written informed consent form (ICF), and agree to cooperate with genetic testing, treatment, efficacy assessment and long-term follow-up. * Age ≥ 18 years Exclusion Criteria: * Female patients who are pregnant, breastfeeding, or of childbearing potential without effective contraception; * Subjects with poorly controlled neurological, psychiatric, mental or cognitive disorders that may impair their understanding and signing of the informed consent form as well as adherence to the study procedures; * Any other conditions deemed inappropriate for enrollment by the investigator.